Delivery Order SPE2DE24D0013-SPE2D625F2PEX
- Not listed
- The U.S. Defense Logistics Agency, operating under the Medical Supply Chain division, awarded a $5,520 firm fixed-price delivery order to Cepheid Inc. on August 20, 2025, with an ultimate completion date of August 27, 2025. This delivery order, designated XPRSTREPA-10, carries no set-aside designation and will be performed at Cepheid's facility in Sunnyvale, California. The contract represents a procurement of molecular diagnostic solutions from Cepheid, a specialized manufacturer of advanced...
- The U.S. Defense Medical Supply Chain awarded a $5,440 firm fixed-price delivery order to Cepheid Inc. on August 28, 2025, with an ultimate completion date of September 5, 2025. This delivery order, contract number XPRS4PLEX-10, carries no set-aside designation and will be performed at Cepheid's headquarters in Sunnyvale, California. Cepheid is a leading manufacturer of molecular diagnostic solutions specializing in advanced diagnostic systems and test kits for infectious diseases and clinical...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a delivery order valued at $4,791.90 by the Defense Logistics Agency's Medical Supply Chain on August 20, 2025, with completion expected by August 27, 2025. This firm fixed-price delivery order carries no set-aside designation and represents a continuation of Cepheid's ongoing provision of diagnostic equipment and reagents to federal healthcare systems. The work will be performed in Sunnyvale,...
- The U.S. Defense Department's Medical Supply Chain division awarded a $95,200 firm fixed-price delivery order to Cepheid Inc. on August 28, 2025, with final completion scheduled for September 5, 2025. This delivery order, designated XPRS4PLEX-10, carries no set-aside designation and represents work to be performed at Cepheid's headquarters in Sunnyvale, California. Cepheid, a leading manufacturer of molecular diagnostic solutions, specializes in GeneXpert diagnostic systems and associated...
- The U.S. Defense Department's Medical Supply Chain organization awarded a delivery order valued at $9,319 to Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, on September 1, 2025. This firm fixed-price delivery order, with an ultimate completion date of September 15, 2025, carries no set-aside designation and represents work to be performed at Cepheid's Sunnyvale facility. The delivery order is issued under one of Cepheid's existing Indefinite Delivery Vehicle...
- This delivery order, awarded July 30, 2025, by the Defense Logistics Agency (under the Medical Supply Chain operations) to Cepheid Inc., carries a firm fixed-price ceiling value of $27,235.80 with an ultimate completion date of August 6, 2025. The contract utilizes no set-aside designation and is performed in Sunnyvale, California, where Cepheid maintains its headquarters. Cepheid, a for-profit manufacturer of molecular diagnostic solutions, will deliver products or services under this...
- The U.S. Defense Department's Medical Supply Chain agency awarded a $1,800 firm fixed-price delivery order to Cepheid Inc., a leading molecular diagnostics manufacturer headquartered in Sunnyvale, California. This delivery order, issued on August 25, 2025, with an ultimate completion date of September 2, 2025, carries no set-aside designation and represents a continuation of the agency's procurement of advanced diagnostic solutions. The work will be performed at Cepheid's Sunnyvale facility....
- This delivery order, valued at $27.2K, was awarded on September 3, 2025, to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. The order is a firm fixed-price award with an ultimate completion date of September 10, 2025, funded by the Medical Supply Chain division within the Department of Defense. The contract carries no set-aside designation and is to be performed in Sunnyvale, California. This delivery order falls under Cepheid's existing Indefinite...
- The U.S. Defense Logistics Agency, operating under the Medical Supply Chain division, awarded a delivery order valued at $4,568.25 to Cepheid Inc. on August 25, 2025, with an ultimate completion date of September 2, 2025. This firm fixed-price delivery order carries no set-aside designation and will be performed at Cepheid's facility in Sunnyvale, California. Cepheid is a for-profit manufacturer of molecular diagnostic solutions specializing in advanced diagnostic systems and test kits for...
- On September 4, 2025, the Defense Logistics Agency's Medical Supply Chain division awarded a $6,195.60 firm fixed-price delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions. The delivery order, designated GXCDIFF/EPI-10, is scheduled for completion by September 11, 2025, and carries no set-aside designation. This award represents a delivery order against one of Cepheid's larger indefinite delivery vehicles, likely the Veterans Integrated...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D625F2PEXDelivery Order
The U.S. Defense Logistics Agency (DLA), operating through its Medical Supply Chain division, awarded a $28,786 firm fixed-price delivery order to Cepheid Inc. on September 4, 2025, with completion scheduled for September 11, 2025. This non-set-aside contract is issued under Cepheid's existing Indefinite Delivery Vehicle (IDV) with the Veterans Integrated Service Network (VISN) 6, a $32.8 million single-award contract that extends through September 30, 2030. The work will be performed at Cepheid's headquarters in Sunnyvale, California. Cepheid, a molecular diagnostics manufacturer, is delivering diagnostic testing solutions—likely including GeneXpert diagnostic systems, reagents, and assays—to support federal healthcare operations. The company specializes in rapid molecular diagnostic technologies for infectious diseases, including COVID-19, influenza, respiratory syncytial virus, and other conditions critical to military and veteran healthcare systems. This delivery order represents routine procurement activity under the broader VISN 6 IDV framework, continuing Cepheid's established role as a key supplier of point-of-care molecular diagnostic capabilities to the Department of Defense and Veterans Affairs healthcare networks.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $28.8k | 9/4/25 |